Contemplating a bone graft.

By: Marseus, Wayne,Hull, Larry D.,Meislin, Rob
Publication: Running & FitNews
Date: Saturday, March 1 2008

I am 52 years old, and have run for 22 years and played all kinds of other sports. I no longer run on pavement. My right knee was diagnosed with osteochondritis dissecans (OCD) and I had meniscus surgery on the same knee a year and a half ago. At the follow-up my surgery recommended that I have

Osteochondral Allograft Transplant Surgery (OATS). I still play volleyball regularly and occasionally will play a game of basketball. I can still jog slowly on a treadmill.

Wayne Marseus

Williamsburg, VA

[Ed. notes: In OCD, which usually affects knees and elbows, a loose piece of bone and cartilage separates from the end of the bone because of a loss of blood supply. The loose piece may fall into the joint space, making the joint unstable. This causes pain and feelings that the joint "sticks."

During OATS, a size-matched donor graft (allograft) is obtained and the diseased cartilage is mapped, and a single, large cylinder of the poor cartilage and underlying bone is removed. The allograft donor cylinder is then inserted into the socket, restoring a normal joint contour.]

There are many issues with osteochondritis and OATS procedure brings more into play. I assume that if allograft is anticipated there must be large OCD lesions, otherwise autograft tissue might be preferable.

I would probably avoid surgery until you do not have other options. Patella-centering braces, NSAIDS, quadrieeps strengthening exercises, and cross-training would all likely be helpful. I would avoid stairs, hills, and the like and never train to excess. Some use glucosamine to their advantage and also injections of viscous material like Synvics.

In the right circumstances OATS is a good procedure. However, if the lesion is small with intact articular cartilage, the bone scan normal, and your symptoms minor, then the real value of the procedure is less evident.

Larry D. Hull, MD

Centralia, WA

In order to make an assessment we'd have to see your MRI as well as an A/P longstanding view of both lower extremities to determine the size of the OCD defect, your weight-bearing alignment, and associated intraarticular knee disease.

My experience with allograft osteochondral grafting have been very encouraging. Results, at least in the short term, are excellent.

Rob Meislin, MD

New York, NY

Related Articles

  • Bone putty used with autogenous bone proves effective.
  • GenSci OrthoBiologics Inc, a subsidiary of GenSci Regeneration Sciences Inc, believes it has a significant product in its DynaGraft bone putty, following publication of a multi-centre posterior lumbar fusion marketing study. The study shows that the bone putty is an ......
  • Therics will launch bone substitute. (Products).
  • A bone graft subsitute for the augmentation of deficient maxillary and mandibular alveolar ridges is being launched by Therics Inc, following US Food and Drug Administration (FDA) approval in spring this year. Therics, a subsidiary of Tredegar Corp, is a ......
  • Fresh-stored osteochondral allograft is now on market.
  • RTI Biologics Inc is launching its fresh-stored osteochondral (OC) allograft line onto the market, following its announcement at the recent annual meting of the American Academy of Orthopaedic Surgeons in San Francisco, USA. Fresh-stored OC allografts provide mature hyaline cartilage ......
  • Canadian firm gains US clearance for orthopaedic products. (Products).
  • A synthetic, resorbable bone graft substitute with an interconnected porosity similar in structure to human cancellous bone has won clearance from the US Food and Drug Administration for its Canadian manufacturer. Millenium Biologix Inc, based in Ontario, will go ahead ......
  • OsteoBiologics offers pre-formed bone repair plugs.
  • In order to respond to the need for preformed materials for osteochondral repair procedures, OsteoBiologics Inc has developed further products to add to its trademarked TruFit bone graft substitute line. The company is offering an 11mm plug, sized to fit ......
  • Book on bone grafting. (Product Marketplace).
  • ASTM International has released Bone Graft Substitutes, a book that presents the clinical and scientific aspects of bone grafting and covers the practical issues of bringing promising new bone-graft substitutes to the marketplace in a way that ensures their safety ......
  • CeraPedics, BioD agree to orthopaedic collaboration.
  • CeraPedics LLC and BioD LLC, both USA, said they have signed an agreement to develop products for the orthopaedic market using the trademarked small peptide P-15 bone graft substitute technology, developed by CeraPedics along with BioD's stem cell procurement procedure....
  • Spineology wins approval for graft.
  • A bone graft containment and reinforcement system for use in vertebral body (intrabody) defects of the spine has gained clearance from the US Food and Drug Administration (FDA) to go to market. The expandable graft containment system, trademarked OptiMesh, is ......
  • Cell implants helpful in knee OA in young patients. (Autologous Chondrocyte Implantation).
  • ORLANDO, FLA. -- Consider autologous chondrocyte implantation a first-line treatment in the young patient with osteoarthritis of the knee who wants to regain the ability to perform physical labor or strenuous sports. About 90% of patients who undergo the procedure ......
  • Orquest and Biopharm firm up deal with Sulzer Spine-Tech.
  • Orquest Inc and Biopharm GmbH signed an agreement giving Sulzer Spine-Tech the exclusive worldwide distribution rights to sell Orquest's bone growth factor product. The agreement does not cover the Japanese market. The product combines Orquest's Healos bone graft substitute and ......
  • Spineology wins CE Mark for graft. (Industry News).
  • Spineology Inc said it has won the CE Mark for its OptiMesh bone graft containment and reinforcement system for use in orthopaedic procedures, including those in the spine. The system can be applied through a minimally-invasive approach and conforms to ......
  • Interpore Cross may have solution to thrombin shortage in Europe.
  • US company Interpore Cross International has signed an agreement for the supply of thrombin, used for healing bone graft sites. In the USA, bovine-derived thrombin is typically available from the hospital supply. However, it is generally not available in many ......
  • Wright Medical wins US approval for bone void fillers.
  • A range of bone graft putties, containing demineralized bone matrix (DBM) and specific volumes and configurations of donor matched, cancellous bone chips, has gained marketing clearance from the US Food and Drug Administration (FDA). Manufacturer Wright Medical Group Inc said ......
  • Collagen Matrix wins CE mark for collagen bone healing patch. (Products).
  • The CE mark has been awarded to the US company Collagen Matrix Inc for its collagen bone healing patch. The collagen-based patch is resorbable and flexible. It is designed to maintain the position of bony fragments and/or bone graft substitute ......
  • Blackstone gets into spine surgery: company signs deal with Berkeley Advanced Biomaterials.
  • Blackstone Medical Inc said it has reached an agreement with Berkeley Advanced Biomaterials Inc to distribute and market Berkeley's synthetic bone graft substitutes for spine surgery applications. Berkeley's hydroxyapatite technology replicates the composition of human bone and can be formed ......

Related Topics